Who Buys Amino from India — 1400 Importers Behind a $322.7M Market

The importers of Amino from India can be categorized into several segments:

1. Distributors: Entities like GRANULES USA INC and SPIRIT PHARMACEUTICALS LLC in the United States fall into this category. They purchase Amino in bulk and distribute it to various healthcare providers, pharmacies, and retailers. Their buying behavior typically involves large, consistent orders to maintain a steady supply chain and meet the demands of their clients.

2. Contract Manufacturers: Companies such as LABORATOIRE RIVA INC in Canada and NELPA LIFESCIENCES INC in the Philippines are contract manufacturers. They procure Amino as a raw material for the production of finished pharmaceutical products. Their order patterns are aligned with production schedules and client demands, often resulting in sizable, periodic purchases.

3. Re-exporters: Entities like SUIPHAR DOMINICANA, S.R.L in the Dominican Republic and NUEVOS ETICOS NEOETHICALS, S.A. in Guatemala may act as re-exporters. They import Amino and subsequently export it to neighboring countries or regions. Their buying behavior is influenced by regional demand and trade agreements, leading to variable order sizes and frequencies.

Each segment's purchasing patterns are influenced by their specific roles in the pharmaceutical supply chain, regulatory requirements, and market demands.

For the top five importing countries, the import regulations for Amino are as follows:

Importers should consult the respective regulatory authorities for the most current and detailed information, as regulations and timelines are subject to change.

The demand for Amino in importing countries is driven by several factors:

1. Disease Prevalence: The prevalence of conditions treated by Amino significantly influences demand. For instance, if Amino is used in the management of cardiovascular diseases, countries with high incidences of such conditions will have increased demand.

2. Government Healthcare Programs: National health initiatives that aim to provide affordable and accessible medications boost the demand for essential drugs like Amino.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential medicines to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: Inclusion of Amino in the WHO Model List of Essential Medicines encourages countries to procure it to ensure the availability of critical treatments.

5. Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals, which can lead to significant orders for Amino, especially when it is included in national essential medicines lists.

With 1,400 buyers across 161 countries, the global reach of Amino underscores its importance in addressing various health conditions and the opportunities for market expansion.

The importers of Amino from India can be categorized into several segments:

1. Distributors: Entities like GRANULES USA INC and SPIRIT PHARMACEUTICALS LLC in the United States fall into this category. They purchase Amino in bulk and distribute it to various healthcare providers, pharmacies, and retailers. Their buying behavior typically involves large, consistent orders to maintain a steady supply chain and meet the demands of their clients.

2. Contract Manufacturers: Companies such as LABORATOIRE RIVA INC in Canada and NELPA LIFESCIENCES INC in the Philippines are contract manufacturers. They procure Amino as a raw material for the production of finished pharmaceutical products. Their order patterns are aligned with production schedules and client demands, often resulting in sizable, periodic purchases.

3. Re-exporters: Entities like SUIPHAR DOMINICANA, S.R.L in the Dominican Republic and NUEVOS ETICOS NEOETHICALS, S.A. in Guatemala may act as re-exporters. They import Amino and subsequently export it to neighboring countries or regions. Their buying behavior is influenced by regional demand and trade agreements, leading to variable order sizes and frequencies.

Each segment's purchasing patterns are influenced by their specific roles in the pharmaceutical supply chain, regulatory requirements, and market demands.

For the top five importing countries, the import regulations for Amino are as follows:

Importers should consult the respective regulatory authorities for the most current and detailed information, as regulations and timelines are subject to change.

The demand for Amino in importing countries is driven by several factors:

1. Disease Prevalence: The prevalence of conditions treated by Amino significantly influences demand. For instance, if Amino is used in the management of cardiovascular diseases, countries with high incidences of such conditions will have increased demand.

2. Government Healthcare Programs: National health initiatives that aim to provide affordable and accessible medications boost the demand for essential drugs like Amino.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential medicines to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: Inclusion of Amino in the WHO Model List of Essential Medicines encourages countries to procure it to ensure the availability of critical treatments.

5. Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals, which can lead to significant orders for Amino, especially when it is included in national essential medicines lists.

With 1,400 buyers across 161 countries, the global reach of Amino underscores its importance in addressing various health conditions and the opportunities for market expansion.